Conceptual Framework
gynecologic cancer, Mishel
GYNECOLOGIC CANCER
Many patients with GC receiving chemotherapy experience high levels of uncertainty in illness [We developed the mobile app for gynecologic cancer support (MGCS) program under the conceptualization of Mishel uncertainty in illness theory. The primary aim of this trial was to examine whether the MGCS program can effectively target uncertainty in illness. We hypothesized that MGCS plus routine care is superior to routine care alone in reducing uncertainty in illness. The subhypotheses were that MGCS plus routine care would improve QoL, reduce symptom distress, and promote social support for patients with GC.